142 related articles for article (PubMed ID: 1360230)
1. c-erbB2 amplification and overexpression in human tumors.
Lofts FJ; Gullick WJ
Cancer Treat Res; 1992; 61():161-79. PubMed ID: 1360230
[TBL] [Abstract][Full Text] [Related]
2. Regulation of expression and transforming ability of the c-erbB-2 gene.
Matsuda S; Akiyama T; Yamada Y; Ishii S; Aizawa S; Mori S; Toyoshima K; Yamamoto T
Princess Takamatsu Symp; 1989; 20():93-101. PubMed ID: 2577338
[TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
Hynes NE
Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP; Strickler JG
Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
[TBL] [Abstract][Full Text] [Related]
7. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
8. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
9. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
Kameda T; Yasui W; Yoshida K; Tsujino T; Nakayama H; Ito M; Ito H; Tahara E
Cancer Res; 1990 Dec; 50(24):8002-9. PubMed ID: 1979253
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
Di Fiore PP; Kraus MH
Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
[No Abstract] [Full Text] [Related]
11. Neu and its ligands: from an oncogene to neural factors.
Peles E; Yarden Y
Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
13. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
[TBL] [Abstract][Full Text] [Related]
14. Role of protein-tyrosine kinases in cellular transformation.
Varticovski L
Sangre (Barc); 1991 Aug; 36(4):305-9. PubMed ID: 1663662
[No Abstract] [Full Text] [Related]
15. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC
Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.
Brysch W; Magal E; Louis JC; Kunst M; Klinger I; Schlingensiepen R; Schlingensiepen KH
Cancer Gene Ther; 1994 Jun; 1(2):99-105. PubMed ID: 7621247
[TBL] [Abstract][Full Text] [Related]
17. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.
D'Souza B; Berdichevsky F; Kyprianou N; Taylor-Papadimitriou J
Oncogene; 1993 Jul; 8(7):1797-806. PubMed ID: 8099725
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.
Shintani S; Funayama T; Yoshihama Y; Alcalde RE; Ootsuki K; Terakado N; Matsumura T
Anticancer Res; 1995; 15(6B):2623-6. PubMed ID: 8669836
[TBL] [Abstract][Full Text] [Related]
19. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
Lacroix H; Iglehart JD; Skinner MA; Kraus MH
Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]